Susquehanna International Group, LLP Alnylam Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

A detailed history of Susquehanna International Group, LLP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 10,817 shares of ALNY stock, worth $2.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,817

Previous 163,734 93.39%

Holding current value

$2.72 Million

Previous $45 Million 94.35%

% of portfolio

0.0%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$232.27 - $300.43 $35.5 Million - $45.9 Million	-152,917 Reduced 93.39%	10,817 $2.55 Million
Q3 2024 Nov 14, 2024	BUY	$233.81 - $287.01 $22.6 Million - $27.8 Million	96,723 Added 144.34%	163,734 $45 Million
Q2 2024 Aug 15, 2024	SELL	$143.31 - $247.0 $2.1 Million - $3.62 Million	-14,651 Reduced 17.94%	67,011 $16.3 Million
Q1 2024 May 07, 2024	BUY	$146.51 - $198.2 $8.15 Million - $11 Million	55,655 Added 214.0%	81,662 $12.2 Million
Q4 2023 Feb 14, 2024	SELL	$151.41 - $196.57 $24.6 Million - $31.9 Million	-162,346 Reduced 86.19%	26,007 $4.98 Million
Q3 2023 Nov 14, 2023	BUY	$170.77 - $211.65 $16.9 Million - $20.9 Million	98,823 Added 110.38%	188,353 $33.4 Million
Q2 2023 Aug 11, 2023	SELL	$185.01 - $212.05 $4.6 Million - $5.27 Million	-24,871 Reduced 21.74%	89,530 $17 Million
Q1 2023 May 16, 2023	BUY	$182.66 - $235.53 $15.3 Million - $19.7 Million	83,736 Added 273.07%	114,401 $22.9 Million
Q4 2022 Feb 14, 2023	SELL	$185.53 - $241.31 $2.18 Million - $2.84 Million	-11,752 Reduced 27.71%	30,665 $7.29 Million
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $2.91 Million - $4.87 Million	-21,011 Reduced 33.13%	42,417 $8.49 Million
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $2.45 Million - $3.44 Million	-20,319 Reduced 24.26%	63,428 $9.25 Million
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $7.53 Million - $10.3 Million	-59,208 Reduced 41.42%	83,747 $13.7 Million
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $15.7 Million - $20.6 Million	98,562 Added 222.02%	142,955 $24.2 Million
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $10.8 Million - $13.3 Million	-63,788 Reduced 58.96%	44,393 $8.38 Million
Q2 2021 Aug 11, 2021	BUY	$128.63 - $176.89 $5.34 Million - $7.34 Million	41,507 Added 62.25%	108,181 $18.3 Million
Q1 2021 May 17, 2021	SELL	$126.83 - $175.69 $1.55 Million - $2.15 Million	-12,254 Reduced 15.53%	66,674 $9.41 Million
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $5.01 Million - $5.98 Million	40,709 Added 106.52%	78,928 $10.3 Million
Q3 2020 Nov 16, 2020	BUY	$121.19 - $165.49 $3.09 Million - $4.22 Million	25,493 Added 200.32%	38,219 $5.56 Million
Q2 2020 Aug 14, 2020	SELL	$104.21 - $156.44 $2.73 Million - $4.09 Million	-26,153 Reduced 67.27%	12,726 $1.89 Million
Q1 2020 May 15, 2020	BUY	$93.12 - $133.99 $37,434 - $53,863	402 Added 1.04%	38,879 $4.23 Million
Q4 2019 Feb 14, 2020	SELL	$74.51 - $124.23 $5.21 Million - $8.68 Million	-69,857 Reduced 64.48%	38,477 $4.43 Million
Q3 2019 Nov 14, 2019	BUY	$70.9 - $87.82 $642,850 - $796,263	9,067 Added 9.13%	108,334 $8.71 Million
Q2 2019 Aug 16, 2019	BUY	$65.86 - $92.79 $1.99 Million - $2.81 Million	30,251 Added 43.83%	99,267 $7.2 Million
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $3.55 Million - $5.01 Million	53,953 Added 358.18%	69,016 $5.01 Million
Q1 2019 May 15, 2019	SELL	$72.76 - $93.45 $4.86 Million - $6.24 Million	-66,766 Reduced 81.59%	15,063 $1.41 Million
Q4 2018 Feb 14, 2019	SELL	$62.67 - $88.33 $464,071 - $654,083	-7,405 Reduced 8.3%	81,829 $5.97 Million
Q3 2018 Nov 14, 2018	BUY	$87.52 - $122.67 $4.22 Million - $5.91 Million	48,210 Added 117.52%	89,234 $7.81 Million
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $152,687 - $186,386	1,729 Added 4.4%	41,024 $4.04 Million
Q1 2018 May 15, 2018	SELL	$115.92 - $148.54 $13.2 Million - $16.9 Million	-113,975 Reduced 74.36%	39,295 $4.68 Million
Q4 2017 Feb 14, 2018	BUY	$114.49 - $139.98 $16.3 Million - $19.9 Million	142,394 Added 1309.25%	153,270 $19.5 Million
Q3 2017 Nov 14, 2017	BUY	$72.53 - $118.27 $788,836 - $1.29 Million	10,876	10,876 $1.28 Million

Others Institutions Holding ALNY

# of Institutions

667

Shares Held

112M

Call Options Held

839K

Put Options Held

771K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.9B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Alnylam Pharmaceuticals, Inc. Transaction History